Connect with BÜHLMANN at UEGW 2019

Offering the broadest fecal calprotectin product portfolio

Calprotectin in IBD Diagnosis and Monitoring

Inflammatory Bowel Disease (IBD) include Crohn’s Disease (CD) and Ulcerative Colitis (UC), two incurable serious chronic diseases of the intestinal tract. IBD symptoms strongly resemble those of non-inflammatory diseases such as irritable bowel syndrome (IBS). Fecal calprotectin has proven itself as an excellent surrogate marker in IBD diagnosis and helps to reliably select patients for further invasive diagnostic procedures. Further, calprotectin in stool can also be used for disease monitoring in diagnosed patients since it correlates closely with mucosal healing. High calprotectin values are indicative for active inflammation in the gut, while moderate fecal calprotectin values can represent mild organic disease.

BÜHLMANN Highlights

New BÜHLMANN Educational Workshop Video

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

BÜHLMANN organized an Educational Workshop at EuroMedLab 2019 about fecal calprotectin testing. Learn more about optimizing your lab workflow for fecal calprotectin, the surrogate biomarker for the assessment of chronic intestinal inflammation.

New BÜHLMANN CALEX® Cap Tutorial Video

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

CALEX® Cap stool extraction device offers an efficient, convenient and hygienic extraction of stool samples and is fully compatible with total laboratory automation (TLA) solutions.

Head-to-head comparison of three stool calprotectin tests for home use

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Two home testing devices measuring fecal calprotectin were compared to a companion ELISA test.

IBDoc® and IBDsmart in the care of inflammatory bowel disease patients

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

The management of IBD using the two different smartphone apps IBDoc® and IBDsmart were compared.

BÜHLMANN fCAL® turbo and BÜHLMANN CALEX® Cap FDA cleared

We are proud to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN fCAL® turbo as well as for the BÜHLMANN CALEX® Cap. The CALEX® Cap stool extraction device offers an efficient, convenient and hygienic extraction of stool samples. Together with BÜHLMANN fCAL® turbo it offers total laboratory automation (TLA) solutions for fecal calprotectin testing. Both, the BÜHLMANN CALEX® Cap and the BÜHLMANN fCAL® turbo were successfully launched all over the world and are now available in the U.S. market.

BÜHLMANN Poster Highlights at UEGW 2019

BÜHLMANN Calprotectin Assays and TDM testing

BÜHLMANN is Gold Standard for IBD diagnosis and monitoring offering the largest product portfolio of calprotectin testing and TDM rapid tests for biologics in IBD. BÜHLMANN offers the FDA cleared market leader BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo for high throughput testing and the rapid Quantum Blue® calprotectin routine POC tests. BÜHLMANN Quantum Blue® TDM rapid tests (Quantum Blue® TDM) offer patients biologics levels within 15 minutes. IBDoc® is the highly successful IBD home test for patients using an app that transforms smart phones into a fecal calprotectin test (fecal calprotectin test) reading device.

The BÜHLMANN Quantum Blue® rapid test combines the ease and speed of lateral flow technology, with full quantification by means of a small, telephone sized reading device. The Quantum Blue® reader provides a quantitative value within minutes and is therefore an ideal tool in a point-of-care setting. The BÜHLMANN product line offers three different fecal calprotectin test (fecal calprotectin test) ranges suitable for IBD diagnosis and therapy follow-up of IBD patients. Besides calprotectin assays, BÜHLMANN offers the possibility for TDM for biologics in IBD as well as for CRP measurement on the Quantum Blue® reader.

BÜHLMANN CALEX® Cap extraction device offers an efficient, convenient and hygienic stool extraction. Its simple design makes it an ideal extraction device characterized not only by high safety but also by offering high stability of stool samples. Furthermore, the CALEX® Cap is fully compatible with total laboratory automation (TLA) solutions increasing the speed of sample processing and reducing hands-on time.

BÜHLMANN has launched its first assay for fecal calprotectin testing (fecal calprotectin testing) more than 10 years ago and is today considered as the gold standard with the BÜHLMANN fCAL® ELISA. Two protocols are available with the BÜHLMANN fCAL® ELISA to cover different calprotectin ranges for IBD diagnosis and monitoring.

BÜHLMANN has recently introduced BÜHLMANN fCAL® turbo, the immuno turbidimetric fecal calprotectin assay (fecal calprotectin assay). The technology of immunoturbidimetry implements a further milestone in fecal calprotectin quantification. It allows very rapid and flexible random access use, as well as being the ideal solution for high throughput applications in the routine laboratory. The assay can be applied on all automated platforms in clinical chemistry and allows short turnaround time from stool sample to reportable result.

IBDoc® is the first in-vitro diagnostic home testing device measuring the inflammatory marker fecal calprotectin at home. The CalApp® turns your smartphone into a test cassette reader using state of the art image processing. Stool extraction is performed using the CALEX® Valve that is characterized by its simple and convenient handling of stool samples. The secure connection of CalApp® with the IBDoc® Portal allows Health Care Professionals to directly monitor patient results.

Free WordPress Themes, Free Android Games